Home > > > Navigating Brazil’s Regulatory Landscape: Achieving Compliance with DDReg Pharma

Navigating Brazil’s Regulatory Landscape: Achieving Compliance with DDReg Pharma

Author : DDReg Pharma | Published On : 09 Apr 2026

The Brazilian pharmaceutical market is one of the most dynamic and stringently regulated in Latin America. For global life sciences companies, entering this territory offers immense opportunity, but it also requires a deep understanding of the Agência Nacional de Vigilância Sanitária (ANVISA). At DDReg Pharma, we bridge the gap between global innovation and local compliance, providing specialized Regulatory Affairs and Pharmacovigilance (PV) services tailored to the Brazilian market.

The ANVISA Challenge: Beyond Just Paperwork

ANVISA is known for its rigorous standards, often harmonizing with international bodies like ICH and WHO, yet maintaining unique local requirements. Successfully launching a product in Brazil isn’t just about submitting a dossier; it’s about strategic alignment.

From ensuring Good Manufacturing Practice (GMP) certification to managing the complexity of eCTD/CTD submissions, the hurdles are significant. This is where DDReg Pharma excels. Our team acts as your strategic partner, offering end-to-end Regulatory Affairs support in Brazil including gap analysis, dossier preparation, and direct liaison with ANVISA — to accelerate your time-to-market.

Strengthening Patient Safety: PV Services in Brazil

Once a product is on the market, the focus shifts to robust monitoring. Under Resolution RDC №406/2020, Brazil has strict guidelines for Good Pharmacovigilance Practices (GVP).

 

DDReg Pharma provides a comprehensive PV framework to safeguard your products and patients, including:

  • Local QPPV/LQPPV Representation: Appointing a dedicated local qualified person as required by law.
  • VigiMed Reporting: Expert management of Individual Case Safety Reports (ICSR) via Brazil’s official platform.
  • Localized Risk Management Plans (RMPs): Tailoring global safety strategies to meet specific Brazilian population needs and regulatory expectations.
  • PSMF Maintenance: Establishing and updating the Brazil-specific Pharmacovigilance System Master File.

Why DDReg Pharma?

With over 16 years of experience and a presence in over 50 countries, DDReg Pharma combines global quality standards with local operational excellence. Whether you are navigating a new product registration or seeking a reliable partner for post-market surveillance, our AI-driven regulatory intelligence and expert-led teams ensure your compliance is never in question.

Partner with DDReg Pharma today and turn regulatory complexity into a competitive advantage in Brazil.

Connect With Us

Stay updated on the latest regulatory insights and industry news by following DDReg Pharma on our social media platforms: